Skip to main content
. 2021 Jan 30;10(4):e018013. doi: 10.1161/JAHA.120.018013

Table 1.

Characteristics of the Patients (Patients From 2007–2009)

No MI/Arrest (n=804 548) MI/Arrest (n=5332) Unadjusted Odds Ratio (95% CI) for MI/Arrest No Stroke (n=807 875) Stroke (n=2005) Unadjusted Odds Ratio (95% CI) For Stroke
Age, y (mean±SD) 55.4 (±17.1) 69.8 (±13.0) 1.059 (1.057–1.061) 55.4 (±17.2) 70.0 (±13.6) 1.06 (1.056–1.063)
Sex (men) (%) 42.52 57.58 1.83 (1.74–1.94) 42.6 48.8 1.29 (1.18–1.4)
ASA class* 1 (%) (Ref=1) 9.90 0.24 9.86 0.40
2 46.00 7.71 6.82 (3.93–11.85) 45.83 10.9 5.89 (2.91–11.93)
3 37.62 48.9 52.83 (30.63–91.11) 37.65 56.26. 36.94 (18.43–74.04)
4 6.20 38.14 248.78 (144.19–429.24) 6.35 30.22 117.58 (58.53–236.21)
5 0.27 5.09 767.5 (439.25–1341.04) 0.30 2.19 182.6 (85.87–388.26)
Diabetes mellitus (%) 14.79 32.15 2.73 (2.58–2.89) 14.9 26.78 2.09 (1.9–2.31)
Alcohol use >2 drinks/day in 2 wks before admission (%) 2.61 3.98 1.54 (1.34–1.77) 2.6 4.84 1.89 (1.54–2.32)
Chemotherapy (%) 1.06 1.82 1.73 (1.42–2.12) 1.06 1.35 1.27 (0.87–1.86)
Disseminated cancer (%) 1.93 4.24 2.25 (1.97–2.57) 1.94 2.74 1.42 (1.09–1.86)
Paraplegia (%) 0.49 0.99 2.04 (1.56–2.68) 0.49 0.75 1.53 (0.92–2.54)
Quadriplegia (%) 0.13 0.43 3.38 (2.24–5.12) 0.13 0.15 1.15 (0.37–3.58)
Hemiplegia (%) 0.92 2.87 3.17 (2.70–3.73) 0.92 6.93 8.01 (6.74–9.54)
Smoker within 1 y (%) 20.68 24.46 1.24 (1.17–1.32) 20.69 26.43 1.38 (1.25–1.52)
Pack‐year of smoking 10.59 23.73 1.02 (1.01–1.02) 10.64 23.44 1.01 (1.01–1.02)
Esophageal varices (%) 0.12 0.32 2.72 (1.68–4.4) 0.12 0.05 0.42 (0.06–2.98)
Chronic obstructive pulmonary disease (%) 4.73 16.97 4.12 (3.83–4.42) 4.79 14.11 3.27 (2.88–3.71)
Ascites (%) 1.01 5.29 5.46 (4.83–6.17) 1.04 2.19 2.14 (1.59–2.89)
Congestive heart failure (%) 0.83 7.28 9.41 (8.46–10.46) 0.86 4.49 5.41 (4.38–6.7)
Myocardial infarction (%) 0.58 5.61 10.2 (9.04–11.5) 0.60 3.84 6.57 (5.22–8.26)
Previous cardiac surgery (%) 5.73 21.23 4.43 (4.15–4.74) 5.80 18.45 3.67 (3.28–4.11)
Previous percutaneous coronary intervention (%) 5.33 17.74 3.83 (3.57–4.11) 5.40 12.77 2.56 (2.25–2.93)
Angina (%) 0.68 4.05 6.12 (5.33–7.04) 0.70 2.84 4.14 (3.18–5.4)
Peripheral vascular disease (%) 4.00 17.18 4.98 (4.63–5.35) 4.06 13.17 3.58 (3.14–4.08)
Hypertension on medication (%) 45.65 77.83 4.18 (3.92–4.46) 45.8 77.61 4. 1 (3.69–4.56)
Acute renal failure (%) 0.55 5.98 11.47 (10.2–12.89) 0.58 3.14 5.55 (4.31–7.14)
Dialysis (%) 1.97 12.23 6.93 (6.38–7.54) 2.03 5.79 2.97 (2.46–3.58)
Steroid (%) 3.05 7.48 2.57 (2.32–2.85) 3.08 5.99 2.01 (1.67–2.41)
Stroke with neurologic deficit (%) 2.30 7.95 3.67 (3.32–4.05) 2.31 15.91 8.02 (7.11–9.04)
Stroke with no neurologic deficit (%) 2.01 6.06 3.14 (2.81–3.52) 2.02 9.93 5.35 (4.62–6.2)
Transient ischemic attack (%) 2.89 7.69 2.8 (2.53–3.09) 2.89 15.31 6.07 (5.37–6.86)
Weight loss (%) 2.23 6.98 3.29 (2.96–3.66) 2.26 4.19 1.89 (1.52–2.36)
Bleeding disorder (%) 5.52 20.46 4.4 (4.11–4.71) 5.58 20.75 4.43 (3.97–4.93)
Emergency (%) 12.39 34.02 3.65 (3.44–3.86) 12.50 26.63 2.54 (2.3–2.81)
Rest Pain (%) 2.28 11.07 5.33 (4.89–5.82) 2.32 8.13 3.72 (3.17–4.37)
White blood count, (109/L) 8.44 10.69 8.45 9.72
Hematocrit (%) 38.98 35.02 38.95 36.61
Platelet (109/L) 261.5 240.72 261.4 246.67
Partial thromboplastin time 30.79 34.61 30.82 33.91
International normalized ratio 1.11 1.28 1.11 1.19
*

ASA class indicates American Society of Anesthesiologists Physical Status Classification; and MI, myocardial infarction.